# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clini...
Carisma retains all rights in autoimmune disease beyond the two nominated targets, which will be exclusively partnered with Mod...
U.S. stocks started the new week with strong gains, as all major indices and sectors in the S&P 500 were in the green by mi...
Moderna's Laval, Quebec, facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vac...
Moderna, Inc. (NASDAQ:MRNA) today announced that its manufacturing facility in Laval, Quebec, has been granted a Drug Establish...